tiprankstipranks
Advertisement
Advertisement
Intensity Therapeutics reports Q1 EPS (96c), consensus ($1.09)
PremiumThe FlyIntensity Therapeutics reports Q1 EPS (96c), consensus ($1.09)
3M ago
Intensity Therapeutics upgraded to Buy from Hold at Freedom Broker
Premium
The Fly
Intensity Therapeutics upgraded to Buy from Hold at Freedom Broker
5M ago
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
Premium
Company Announcements
U.S. Tariff and Trade Policy Risks Threaten Intensity Therapeutics’ Supply Chain, Costs, and Stock Valuation
5M ago
Intensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
PremiumPre-EarningsIntensity Therapeutics, Inc. (INTS) Q4 Earnings Cheat Sheet
5M ago
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
Premium
Company Announcements
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing
5M ago
Intensity Therapeutics regains Nasdaq compliance
Premium
The Fly
Intensity Therapeutics regains Nasdaq compliance
5M ago
Intensity Therapeutics to ‘opportunistically raise additional capital’ in 2026
PremiumThe FlyIntensity Therapeutics to ‘opportunistically raise additional capital’ in 2026
7M ago
Intensity Therapeutics to present two posters ay SABCS
Premium
The Fly
Intensity Therapeutics to present two posters ay SABCS
8M ago
Intensity Therapeutics Granted Nasdaq Compliance Extension
Premium
Company Announcements
Intensity Therapeutics Granted Nasdaq Compliance Extension
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100